Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna's $1 Billion Revenue Forecast Cut Sends Stock Plummeting Over 20%
12:01pm, Monday, 13'th Jan 2025
Shares of pharmaceutical giant Moderna (MRNA) plunged Monday after the company cut its 2025 revenue forecast by $1 billion.
Why Moderna Stock Just Crashed 21%
11:46am, Monday, 13'th Jan 2025
Moderna's (MRNA -21.95%) sales are slowing down, and Moderna stock is going down -- a lot.
Moderna Stock Heads for Worst Day Ever on Forecast Cut
10:34am, Monday, 13'th Jan 2025
Moderna Inc (NASDAQ:MRNA) lowered its 2025 revenue forecast to a range of $1.5 billion to $2.5 billion, marking a $1 billion reduction from previous estimates.
Moderna Stock Heads for Worst-Ever Day After Reducing Revenue Forecast
10:34am, Monday, 13'th Jan 2025
Moderna Inc (NASDAQ:MRNA) lowered its 2025 revenue forecast to a range of $1.5 billion to $2.5 billion, marking a $1 billion reduction from previous estimates.
Cramer's Stop Trading: Moderna
10:19am, Monday, 13'th Jan 2025
CNBC's Jim Cramer explains why he is keeping an eye on shares of Moderna.
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance
10:17am, Monday, 13'th Jan 2025
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative. The post Moderna Stock Crashes 21% After Covid Vaccine Maker Slas
TSLA Bull's A.I. Thesis, LULU Ups Guidance & MRNA Plunges
10:07am, Monday, 13'th Jan 2025
Morgan Stanley raised its price target on Tesla (TSLA) with optimism behind the company's A.I. and autonomous driving expectations.
Moderna Expects Lower Annual Sales, Expands Cost-Cutting Initiatives
09:33am, Monday, 13'th Jan 2025
Moderna Inc. MRNA stock plunged on Monday after the company announced business updates and progress across its pipeline. Moderna says it enters 2025 with a focus on a prioritized portfolio addressing
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
08:19am, Monday, 13'th Jan 2025
Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of wh
Moderna's stock tumbles to post-COVID lows after revenue outlook disappoints
08:11am, Monday, 13'th Jan 2025
Moderna's stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.
Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.
07:10am, Monday, 13'th Jan 2025
The company said Monday that it expects 2025 revenue of between $1.5 billion and $2.5 billion.
Moderna cuts 2025 sales view on slow start to RSV shot, weak COVID vaccine demand
07:04am, Monday, 13'th Jan 2025
Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines.
Moderna Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
07:00am, Monday, 13'th Jan 2025
Achieved 2024 product sales of $3.0 to 3.1 billion (unaudited) and an ending cash balance of approximately $9.5 billion (unaudited) Updates 2025 expected revenue range to $1.5 to 2.5 billion Expects t
mRNA Cancer Vaccines Clinical Trials Ongoing Research Development Insight
08:34am, Thursday, 09'th Jan 2025
First Commercial mRNA Vaccine Approval Expected By 2029 Says Kuick Research First Commercial mRNA Vaccine Approval Expected By 2029 Says Kuick Research
Moderna Shares Spike on H5N1 News—What's Next for Investors?
10:39am, Wednesday, 08'th Jan 2025
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
